Finance

Beta
Lists
DDNB34:BVMF
Dupont De Nemours Inc BDR
R$248.41
0.00%
(0.00) 1D
May 26, 4:49:11 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DDNB34...
Mkt. cap
19.43B
Avg. vol.
102.00
Volume
0.00
52-wk high
R$440.47
52-wk low
R$199.64
Shares outstanding
409.92M
No. of employees
15K
Mkt. cap
19.43B
Avg. vol.
102.00
Volume
0.00
52-wk high
R$440.47
52-wk low
R$199.64
Shares outstanding
409.92M
No. of employees
15K
News stories
From sources across the web
Profile
DuPont de Nemours, Inc., commonly shortened to DuPont, is an American diversified resource and specialty chemical conglomerate headquartered and organized in Delaware. The brand produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 as a gunpowder mill by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company operates two divisions: Healthcare & Water Technologies, which produces medical packaging such as Tyvek packaging and TYCHEM protective suits as well as AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements and INGE and ITEGRATEC ultrafiltration modules; and Diversified Industrials, which produces products for repair‑and‑remodel construction such as Tyvek house wrap, Styrofoam insulation, CORIAN, Vespel shapes and parts, MOLYKOTE lubricants, BETAFORCE, and BETASEAL. In 2015, DuPont and the Dow Chemical Company agreed to a reorganization plan in which the two companies would merge and split into three. As a merged entity, DuPont simultaneously acquired Dow and renamed itself to DowDuPont on August 31, 2017. Wikipedia
About Dupont De Nemours Inc BDR
CEOLori Koch
Employees15K
FoundedAug 31, 2017
Headquarters-
SectorSpeciality chemicals
Websitedupont.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.58B
3.07B
-1.87B
1.68B
Cost of goods sold
1.50B
1.88B
-816.00M
1.08B
Cost of revenue
1.50B
1.88B
-816.00M
1.08B
Research and development expenses
127.00M
140.00M
-211.00M
47.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
371.00M
388.00M
-111.00M
255.00M
Operating expense
606.00M
649.00M
-406.00M
370.00M
Total operating expenses
2.11B
2.53B
-1.22B
1.45B
Operating income
471.00M
546.00M
-649.00M
232.00M
Other non operating income
64.00M
5.00M
-46.00M
10.00M
EBT including unusual items
1.04B
327.00M
-738.00M
181.00M
EBT excluding unusual items
391.00M
482.00M
-719.00M
221.00M
Income tax expense
53.00M
19.00M
-89.00M
31.00M
Effective tax rate
5.10%
5.81%
12.06%
17.13%
Other operating expenses
-
-
-
-
Net income
59.00M
-123.00M
-126.00M
161.00M
Net profit margin
2.29%
-4.00%
6.73%
9.58%
Earnings per share
1.12
1.09
0.46
0.55
Interest and investment income
20.00M
27.00M
30.00M
10.00M
Interest expense
-162.00M
-99.00M
-16.00M
-40.00M
Net interest expenses
-142.00M
-72.00M
14.00M
-30.00M
Depreciation and amortization charges
-
-
-84.00M
-
EBITDA
767.00M
729.00M
-487.25M
387.00M
Gain or loss from assets sale
6.00M
-
-3.00M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer